Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid).

Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Abstract Text:

Meng Deng,Lakshmi S Nair,Syam P Nukavarapu,Sangamesh G Kumbar,Tao Jiang,Nicholas R Krogman,Anurima Singh,Harry R Allcock,Cato T Laurencin,Meng Deng,Lakshmi S Nair,Syam P Nukavarapu,Sangamesh G Kumbar,Tao Jiang,Nicholas R Krogman,Anurima Singh,Harry R Allcock,Cato T Laurencin,

Previously we demonstrated the ability of ethyl glycinato substituted polyphosphazenes to neutralize the acidic degradation products and control the degradation rate of poly(lactic acid-glycolic acid) (PLAGA) by blending. In this study, blends of high strength poly[(50% ethyl alanato) (50% p-phenyl phenoxy) phosphazene] (PNEA(50)PhPh(50)) and 85:15 PLAGA were prepared using a mutual solvent approach. Three different solvents, methylene chloride (MC), chloroform (CF) and tetrahydrofuran (THF) were studied to investigate solvent effects on blend miscibility. Three different blends were then fabricated at various weight ratios namely 25:75 (BLEND25), 50:50 (BLEND50), and 75:25 (BLEND75) using THF as the mutual solvent. The miscibility of the blends was evaluated by scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR). Among these, BLEND25 was miscible while BLEND50 and BLEND75 were partially miscible. Furthermore, BLEND25 formed apatite layers on its surface as evidenced in a biomimetic study performed. These novel blends showed cell adhesion and proliferation comparable to PLAGA. However, the PNEA(50)PhPh(50) component in the blends was able to increase the phenotypic expression and mineralized matrix synthesis of the primary rat osteoblasts (PRO) in vitro. Blends of high strength PNEA(50)PhPh(50) and 85:15 PLAGA are promising biomaterials for a variety of musculoskeletal applications.

Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Publishing Authors By Initials

M Deng,LS Nair,SP Nukavarapu,SG Kumbar,T Jiang,NR Krogman,A Singh,HR Allcock,CT Laurencin,M Deng,LS Nair,SP Nukavarapu,SG Kumbar,T Jiang,NR Krogman,A Singh,HR Allcock,CT Laurencin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biomaterials

VOLUME: 29

Page Numbers: 337-49

Journal Abbreviation:

ISSN: 0142-9612

DAY: 17

MONTH: 10

YEAR: 2007

Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8100316

Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid).

AFFILIATION: Department of Chemical Engineering, University of Virginia, Charlottesville, VA 22904, USA.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biomaterials

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Miscibility and in vitro osteocompatibility of biodegradable blends of polyethyl alanato p-phenyl phenoxy phosphazene and polylactic acid-glycolic acid Related Publications

• Amorphous hydroxyapatite-sintered polymeric scaffolds for bone tissue regeneration: Physical characterization studies.
• Apatite nano-crystalline surface modification of poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering: implications for protein adsorption.
• Biologically active chitosan systems for tissue engineering and regenerative medicine.
• Biomimetic tissue-engineered anterior cruciate ligament replacement.
• Cato T. Laurencin, MD, PhD.
• Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications.
• Electrospun nanofiber scaffolds: engineering soft tissues.
• Electrospun poly(lactic acid-co-glycolic acid) scaffolds for skin tissue engineering.
• Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.
• Fracture repair with ultrasound: clinical and cell-based evaluation.
• Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.
• In vitro and in vivo evaluation of a novel polymer-ceramic composite scaffold for bone tissue engineering.
• Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach.
• Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid).
• Nanofibers and nanoparticles for orthopaedic surgery applications.
• Novel low temperature setting nanocrystalline calcium phosphate cements for bone repair: osteoblast cellular response and gene expression studies.
• Novel tubular composite matrix for bone repair.
• Polymers as biomaterials for tissue engineering and controlled drug delivery.
• Polyphosphazene/nano-hydroxyapatite composite microsphere scaffolds for bone tissue engineering.
• Solvent/non-solvent sintering: a novel route to create porous microsphere scaffolds for tissue regeneration.
• Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair.
• Tissue engineering of bone: material and matrix considerations.
• Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix.